• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌转移的表观遗传调控。

Epigenetic regulation of breast cancer metastasis.

机构信息

Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Lauterbur Drive, Stony Brook, NY, 11794, USA.

出版信息

Cancer Metastasis Rev. 2024 Jun;43(2):597-619. doi: 10.1007/s10555-023-10146-7. Epub 2023 Oct 19.

DOI:10.1007/s10555-023-10146-7
PMID:37857941
Abstract

Breast cancer is the most frequently diagnosed malignancy and the second leading cause of cancer-related mortality among women worldwide. Recurrent metastasis is associated with poor patient outcomes and poses a significant challenge in breast cancer therapies. Cancer cells adapting to a new tissue microenvironment is the key event in distant metastasis development, where the disseminating tumor cells are likely to acquire genetic and epigenetic alterations during the process of metastatic colonization. Despite several decades of research in this field, the exact mechanisms governing metastasis are not fully understood. However, emerging body of evidence indicates that in addition to genetic changes, epigenetic reprogramming of cancer cells and the metastatic niche are paramount toward successful metastasis. Here, we review and discuss the latest knowledge about the salient attributes of metastasis and epigenetic regulation in breast cancer and crucial research domains that need further investigation.

摘要

乳腺癌是全球女性中最常见的恶性肿瘤,也是癌症相关死亡的第二大主要原因。复发性转移与患者预后不良有关,是乳腺癌治疗的重大挑战。癌细胞适应新的组织微环境是远处转移发展的关键事件,在转移定植过程中,播散的肿瘤细胞可能获得遗传和表观遗传改变。尽管该领域已经进行了几十年的研究,但转移的确切机制仍不完全清楚。然而,越来越多的证据表明,除了遗传变化外,癌细胞的表观遗传重编程和转移生态位对成功转移至关重要。在这里,我们回顾和讨论了有关乳腺癌转移和表观遗传调控的最新知识,以及需要进一步研究的关键研究领域。

相似文献

1
Epigenetic regulation of breast cancer metastasis.乳腺癌转移的表观遗传调控。
Cancer Metastasis Rev. 2024 Jun;43(2):597-619. doi: 10.1007/s10555-023-10146-7. Epub 2023 Oct 19.
2
Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.乳腺癌转移:机制与治疗意义。
Int J Mol Sci. 2022 Jun 18;23(12):6806. doi: 10.3390/ijms23126806.
3
Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma.HGF/Met受体轴的表观遗传调控对于乳腺癌骨转移的发生发展至关重要。
Cell Death Dis. 2017 Feb 2;8(2):e2578. doi: 10.1038/cddis.2016.403.
4
miRNAs: Critical mediators of breast cancer metastatic programming.miRNAs:乳腺癌转移编程的关键介质。
Exp Cell Res. 2021 Apr 1;401(1):112518. doi: 10.1016/j.yexcr.2021.112518. Epub 2021 Feb 17.
5
Tumor Microenvironment and Epigenetic Implications in Breast Cancer Progression.肿瘤微环境与乳腺癌进展中的表观遗传学意义。
Adv Exp Med Biol. 2024;1465:15-36. doi: 10.1007/978-3-031-66686-5_2.
6
Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.前列腺素 E2 和白细胞介素 6 在远处转移部位诱导 DNMT3B 的表达,促进了表观遗传修饰和乳腺癌的定植。
Cancer Res. 2020 Jun 15;80(12):2612-2627. doi: 10.1158/0008-5472.CAN-19-3339. Epub 2020 Apr 7.
7
Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives.乳腺癌肺转移的分子机制:临床与实验透视。
Int J Mol Sci. 2019 May 8;20(9):2272. doi: 10.3390/ijms20092272.
8
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies.乳腺癌微环境中的表观遗传失调:对肿瘤进展和治疗策略的影响。
Biomed Pharmacother. 2024 May;174:116559. doi: 10.1016/j.biopha.2024.116559. Epub 2024 Apr 10.
9
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.使用全基因组启动子平铺微阵列在乳腺癌转移模型中进行表观遗传图谱绘制和功能分析。
Breast Cancer Res. 2008;10(4):R62. doi: 10.1186/bcr2121. Epub 2008 Jul 18.
10
Obesity-associated epigenetic alterations and the obesity-breast cancer axis.肥胖相关的表观遗传改变与肥胖-乳腺癌轴
Oncogene. 2024 Mar;43(11):763-775. doi: 10.1038/s41388-024-02954-0. Epub 2024 Feb 3.

引用本文的文献

1
Metastatic hepatic carcinoma: Mechanisms, emerging therapeutics, and future perspectives.转移性肝癌:机制、新兴疗法及未来展望
iScience. 2025 Jun 14;28(7):112902. doi: 10.1016/j.isci.2025.112902. eCollection 2025 Jul 18.
2
CD151 Promotes Cancer Progression in Triple-Negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway.CD151通过丝裂原活化蛋白激酶(MAPK)信号通路诱导上皮-间质转化(EMT),促进三阴性乳腺癌的进展。
Breast Cancer (Dove Med Press). 2025 May 28;17:455-470. doi: 10.2147/BCTT.S518760. eCollection 2025.
3
Non-coding RNAs as key regulators of epithelial-mesenchymal transition in breast cancer.

本文引用的文献

1
Nicotinamide N-methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer.烟酰胺 N-甲基转移酶维持了一个核心的表观遗传程序,促进了乳腺癌的转移性定植。
EMBO J. 2023 Jul 3;42(13):e112559. doi: 10.15252/embj.2022112559. Epub 2023 Jun 1.
2
Pan-cancer whole-genome comparison of primary and metastatic solid tumours.泛癌种原发性和转移性实体瘤全基因组比较
Nature. 2023 Jun;618(7964):333-341. doi: 10.1038/s41586-023-06054-z. Epub 2023 May 10.
3
Genetic immune escape landscape in primary and metastatic cancer.
非编码RNA作为乳腺癌上皮-间质转化的关键调节因子
Front Cell Dev Biol. 2025 Mar 25;13:1544310. doi: 10.3389/fcell.2025.1544310. eCollection 2025.
4
Super-enhancer-hijacking RBBP7 potentiates metastasis and stemness of breast cancer via recruiting NuRD complex subunit LSD1.超级增强子劫持的RBBP7通过招募核小体重塑去乙酰化酶(NuRD)复合物亚基LSD1增强乳腺癌的转移和干性。
J Transl Med. 2025 Mar 4;23(1):266. doi: 10.1186/s12967-025-06270-3.
5
IR813-Induced Photothermal Therapy: Leveraging Immunogenic Cell Death for Cancer Treatment.IR813诱导的光热疗法:利用免疫原性细胞死亡进行癌症治疗。
Pharmaceutics. 2025 Jan 26;17(2):166. doi: 10.3390/pharmaceutics17020166.
6
SMYD4 promotes MYH9 ubiquitination through lysine monomethylation modification to inhibit breast cancer progression.SMYD4通过赖氨酸单甲基化修饰促进MYH9泛素化,以抑制乳腺癌进展。
Breast Cancer Res. 2025 Feb 10;27(1):20. doi: 10.1186/s13058-025-01973-3.
7
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.长链非编码RNA SOX2-OT在癌症和非恶性疾病中的新作用。
J Physiol Biochem. 2025 Feb;81(1):57-83. doi: 10.1007/s13105-024-01059-2. Epub 2024 Dec 20.
8
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT3.GdX 通过负向调节 STAT3 的活性抑制乳腺癌的发生和发展。
Cancer Biol Ther. 2024 Dec 31;25(1):2420383. doi: 10.1080/15384047.2024.2420383. Epub 2024 Nov 2.
9
Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes.免疫疗法正在彻底改变脑转移癌的治疗:个性化策略带来变革性的结果。
Front Immunol. 2024 Jul 29;15:1418580. doi: 10.3389/fimmu.2024.1418580. eCollection 2024.
原发性和转移性癌症中的遗传免疫逃逸景观。
Nat Genet. 2023 May;55(5):820-831. doi: 10.1038/s41588-023-01367-1. Epub 2023 May 10.
4
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression.组蛋白去乙酰化酶抑制剂通过上调 NEDD9 表达促进乳腺癌转移。
Signal Transduct Target Ther. 2023 Jan 6;8(1):11. doi: 10.1038/s41392-022-01221-6.
6
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.AURORA US 网络的原发性和转移性乳腺癌的多组学研究发现了转移的微环境和表观遗传驱动因素。
Nat Cancer. 2023 Jan;4(1):128-147. doi: 10.1038/s43018-022-00491-x. Epub 2022 Dec 30.
7
DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy.用于通过液体活检对三阴性乳腺癌进行无创检测的DNA甲基化生物标志物。
Int J Cancer. 2023 Mar 1;152(5):1025-1035. doi: 10.1002/ijc.34337. Epub 2022 Nov 8.
8
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies.乳腺癌中的表观遗传学与环境:抗癌治疗的新范式
Front Oncol. 2022 Sep 15;12:971288. doi: 10.3389/fonc.2022.971288. eCollection 2022.
9
Deletion of mdig enhances H3K36me3 and metastatic potential of the triple negative breast cancer cells.mdig基因的缺失增强了三阴性乳腺癌细胞的H3K36me3水平和转移潜能。
iScience. 2022 Sep 3;25(10):105057. doi: 10.1016/j.isci.2022.105057. eCollection 2022 Oct 21.
10
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis.肿瘤干细胞调控的表型可塑性保护转移性癌细胞免受铁死亡。
Nat Commun. 2022 Mar 16;13(1):1371. doi: 10.1038/s41467-022-29018-9.